Alnylam Pharmaceuticals competitors

Alnylam Pharmaceuticals Competitors include Moderna Therapeutics, Immune Therapeutics, Celyad and Aerie Pharmaceuticals.
Add company...
Alnylam Pharmaceuticals
Alnylam Pharmaceuticals
Alnylam is a biopharmaceutical company developing novel therapeutics based on RNA interference, or RNAi.
Moderna Therapeutics
Moderna Therapeutics
Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.
Immune Therapeutics
Immune Therapeutics
Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing and distribution of immunotherapies.
Celyad
Celyad
Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.
Aerie Pharmaceuticals
Aerie Pharmaceuticals
Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.
Founding Date
Founding Date
2002
Founding Date
N/A
Founding Date
2012
Founding Date
2007
Founding Date
2005
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Zug, CH
Windsor And Maidenhead, GB
Locations
Cambridge, US HQ
Huddinge, SE
Chicago, US
Norwood, US
Huntington, US
Cambridge, US
Cambridge, US
Locations
Orlando, US HQ
Locations
Mont-Saint-Guibert, BE HQ
Boston, US
Locations
Irvine, US HQ
Dublin, IE
Durham, US
Bedminster Township, US
Employees
Employees
514
Employees
7213% increase
Employees
10
Employees
801% increase
Employees
9536% increase
Valuation ($)
Valuation ($)
7.9 b
Valuation ($)
N/A
Valuation ($)
4.4 m
Valuation ($)
205.7 b
Valuation ($)
1.9 b
Twitter followers
Twitter followers
8 k
Twitter followers
2.4 k
Twitter followers
94
Twitter followers
1.6 k
Twitter followers
N/A

Financial

Revenue (est.)
Revenue (est.)
N/A
Revenue (est.)
$205.8m (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
€3.5m (FY, 2017)
Revenue (est.)
N/A
Net income
Net income
($490.9m) (FY, 2017)
Net income
($255.9m) (FY, 2017)
Net income
($7.9m) (FY, 2017)
Net income
(€56.4m) (FY, 2017)
Net income
($145.1m) (FY, 2017)

Funding

Total funding raised
Total funding raised
$ 710m
Total funding raised
$ 1.7b
Total funding raised
N/A
Total funding raised
N/A
Total funding raised
$ 388.6m
For sources of this data, please see the company profileDownload Excel

View company profiles

Moderna Therapeutics
HQ
Cambridge, US
Employees
721↑ 3% increase

Moderna Therapeutics develops messenger RNA therapeutics that produces human proteins for antibodies inside patient cells.

View company
Immune Therapeutics
HQ
Orlando, US
Employees
10

Immune Therapeutics is a specialty pharmaceutical company involved in the manufacturing and distribution of immunotherapies.

View company
Celyad
HQ
Mont-Saint-Guibert, BE
Employees
80↑ 1% increase

Celyad is a biopharmaceutical company focused on the discovery and development of regenerative and protective therapies in cardiology and oncology.

View company
Aerie Pharmaceuticals
HQ
Irvine, US
Employees
95↑ 36% increase

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with glaucoma and other diseases of the eye.

View company